Search Results
Dec 12, 2025, 21:48 ET Loop lanserar en flugfiskeserie på YouTube som belyser bevarande och anknytning
13 december 2025 /PRNewswire/ -- Wild Fish. Wild Places. with Emilie Björkman, en fängslande ny YouTube-serie i dokumentär stil med miljöaktivisten och den berömda flugfiskaren Emilie Björkman, lanserades i höstas. Serien är producerad av Loop, ett företag som är engagerat i att tillverka
More news about: Loop
Dec 12, 2025, 09:18 ET AusperBio Announces AHB-137 Monotherapy Achieved 30% Functional Cure Rate in HBe-negative CHB Patients on Stable Nucleos(t)ide Analogue (NA) Therapy
has developed a proprietary Med-Oligo™ ASO platform which has been shown to substantially enhance the current ASO therapeutics, through novel insights into ASO design. Combining efficient targeted delivery conjugation technologies, the modular Med-Oligo™ Platform empowers ASO therapeutics
More news about: AusperBio Therapeutics Inc.
Dec 12, 2025, 09:00 ET BoomRx Debuts Single Portal for Prescription Sourcing and Fulfillment
system.Built to eliminate the inefficiencies of managing multiple pharmacy portals, state-by-state shipping rules, and fragmented pricing, BoomRx enables med spas, wellness clinics, telemedicine providers, hormone-therapy practices, and other physician offices to access a wide portfolio of medications—including
More news about: BoomRx
Dec 11, 2025, 18:09 ET FDA APPROVES UPLIZNA® FOR ADULTS WITH GENERALIZED MYASTHENIA GRAVIS
2024;69(2):166-171.Nowak R, Benatar M, Ciafaloni E, et al. A phase 3 trial of inebilizumab in generalized myasthenia gravis. N Engl J Med. 2025;392(23):2309-2320.Amgen Inc. UPLIZNA (inebilizumab-cdon) US prescribing information. Revised December 2025.Lazaridis K, Tzartos
More news about: Amgen
Dec 11, 2025, 16:40 ET InstaMed® Pharmaceuticals Announces Month-Over-Month Hypergrowth, Successful Study, and Expands Its Patented Peptide Delivery Platform Nationwide
Today, the company announced unprecedented month-over-month growth as demand accelerates across med spas, healthcare clinics, affiliate networks, and wellness channels nationwide. It currently holds nine pending patents.InstaMeds' breakthrough
More news about: InstaMed® Pharmaceuticals
Dec 11, 2025, 14:28 ET Empower Mental Health & Wellness Clinic Joins National Initiative to Support Firefighters' Mental Wellness
BTL is a global leader in medical devices, providing innovative solutions in dermatology, plastic surgery, med spas, orthopedics, joint and spine care, rehabilitation, dentistry, primary care, OB/GYN, and more.
More news about: Empower Mental Health and Wellness
Dec 11, 2025, 10:00 ET Cision förvärvar Trajaan, utökar AI och sökintelligens över sina plattformar
bild av röst och avsiktKunder kommer nu att kunna kombinera sociala och medieinsikter med sökintelligens för att validera trender, förutsäga efterfrågan och förstå konsumenternas motivationer med större djup.Synlighet i GenAI-driven upptäcktEftersom generativ AI i allt högre
More news about: Cision Ltd.
Dec 11, 2025, 08:30 ET WERFEN APPLAUDS SIGNIFICANT PUBLICATION URGING ACTION ON THE RISKS OF UNDETECTED HEMOLYSIS
opportunities for quality improvement. Clin Chem Lab Med. 2009;47(5):616–618. doi:10.1515/CCLM.2009.132Lippi G, Fontana R, Avanzini P, Sandei F, Ippolito L. Influence of spurious hemolysis on blood gas analysis. Clin Chem Lab Med. 2013;51(8):1651–1654. doi:10.1515/cclm-2012-0802O'Hara
More news about: Werfen
Dec 11, 2025, 08:10 ET ProPharma Expands Operations with New Office in Hyderabad
ProPharmaFor the last 25 years, ProPharma has improved the health and wellness of patients by providing advice and expertise that empowers biotech, med device, and pharmaceutical organizations of all sizes to confidently advance scientific breakthroughs and introduce new therapies. With deep domain expertise
More news about: ProPharma Group Holdings LLC
Dec 11, 2025, 08:10 ET ProPharma Expands Operations with New Office in Hyderabad
ProPharmaFor the last 25 years, ProPharma has improved the health and wellness of patients by providing advice and expertise that empowers biotech, med device, and pharmaceutical organizations of all sizes to confidently advance scientific breakthroughs and introduce new therapies. With deep domain expertise
More news about: ProPharma Group Holdings LLC
Dec 10, 2025, 18:30 ET Astellas to Present New Clinical Data Across Its Gastrointestinal Cancers Portfolio at 2026 ASCO GI Cancers Symposium
MA, et al. Zolbetuximab plus CAPOX in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: the randomized, phase 3 GLOW trial. Nat Med. 2023;29(8):2133-2141.3 Lee, JK et al. Comprehensive pan-cancer genomic landscape of KRAS altered cancers and real-world outcomes
More news about: Astellas Pharma Inc.
Dec 10, 2025, 17:45 ET ECOG-ACRIN and Caris Life Sciences unveil first findings from a multi-year collaboration to advance AI-powered multimodal tools for breast cancer recurrence risk stratification
are postmenopausal or older than 50 at diagnosis, and also in most patients who are younger than 50 or premenopausal (Sparano JA et al. N Engl J Med. 2018). With longer follow-up (12 years of survival and recurrence outcomes), the main study findings remain unchanged.One critically important
More news about: Caris Life Sciences
Dec 10, 2025, 11:12 ET Lucinity lanserer Human AI-drevne FinCrime-operasjoner og utnevner ny administrerende direktør for neste kapittel
regulatoriske forventninger. Mens mange ønsker fordelene med AI, sliter de fleste med å ta det i bruk på grunn av eldre systemer, styringsmessige begrensninger og operasjonell risiko.Lucinitys nye tjeneste løser dette problemet ved å ta på seg arbeidsmengden med FinCrime-etterforskning under SLA, mens institusjonene
More news about: Lucinity
Dec 10, 2025, 11:03 ET Lucinity lanserar Human AI-drivna FinCrime-operationer och utser ny VD för nästa kapitel
Chairman.Förstärkt styrelse och nordisk momentumLucinity har utökat sin styrelse med Kristian Nygaard Johansen och Bragi Fjalldal, tillsammans med stöd från Eric från byFounders. Styrelsen för med sig djup erfarenhet av att skala nordiska finansiella och teknikföretag."Det finns tydlig
More news about: Lucinity
Dec 10, 2025, 10:58 ET Lucinity lancerer Human AI-drevne FinCrime-operationer og udnævner ny administrerende direktør til næste kapitel
styring."GK vil fortsætte med at vejlede Lucinitys langsigtede vision, innovation og strategiske partnerskaber som Executive Chairman.Styrket bestyrelse og nordisk momentumLucinity har udvidet sin bestyrelse med Kristian Nygaard Johansen og Bragi Fjalldal, sammen med støtte fra Eric fra
More news about: Lucinity
Dec 10, 2025, 08:01 ET ProRx Pharma Expands State-of-the-Art Facilities to Fuel Growing Demand for Personalized and Preventative Medicine
safe, compliant, and high-quality compounded sterile and nonsterile preparations to physician practices, medical clinics, and med spas across the country. With a focus on preventative health, regulatory excellence, reliability, and customer service, ProRx partners
More news about: ProRx Pharma
Dec 09, 2025, 19:26 ET Innovent Announces First Participant Dosed in a Phase 1 Clinical Trial of IBI3011, a Recombinant Anti-Human Interleukin 1 Receptor Accessory Protein Monoclonal Antibody
References[1]. J Transl Int Med. 2022;10(2):134-145[2]. Sci
More news about: Innovent Biologics
Dec 09, 2025, 14:06 ET NCCN Summit Seeks to Improve Care for Veterans and First Responders with Cancer from Line-of-Duty Exposure
hope and life-saving cancer care. No one who served should have to fight for cancer treatment or access to clinical trials," agreed Mel Mann, MBA, MEd, U.S. Army Major (retired), Survivor, Advocate.Speakers noted that veterans and firefighters can face elevated risk due to exposures while
More news about: National Comprehensive Cancer Network
Dec 09, 2025, 10:00 ET Cision utnämner Amy Jones till Chief Marketing Officer
Vistaprint. "Jag är exalterad över att gå med i Cision vid ett sådant avgörande ögonblick", säger Amy Jones, CMO för Cision. Cisions skala, data och AI-drivna innovation utgör en enorm möjlighet. Jag ser fram emot att samarbeta med ELT och våra globala team för att påskynda tillväxten
More news about: Cision Ltd.
Dec 09, 2025, 01:00 ET Azorus CRM åbner kontor i København for at kunne yde tættere og mere responsiv support til nordiske og europæiske universitetspartnere
partnerskab. Nathans ekspertise inden for videregående uddannelse og førstehåndserfaring med Azorus gør ham til det perfekte supplement til vores team, da vi fortsætter med at hjælpe universiteter i Storbritannien og Europa med at nå deres mål for studenterengagement."Kontoret i København afspejler
More news about: AZORUS CRM
Dec 09, 2025, 01:00 ET Azorus CRM åpner kontor i København for å levere nærere og mer responsiv støtte til nordiske og europeiske universitetspartnere
meningsfylt nivå av partnerskap. Nathans høyere utdanningsekspertise og førstehåndserfaring med Azorus gjør ham til det perfekte tilskuddet til vårt team, ettersom vi fortsetter å hjelpe universiteter i Storbritannia og Europa med å nå sine mål for studentengasjement."Kontoret i København gjenspeiler
More news about: AZORUS CRM
Dec 09, 2025, 01:00 ET Håvors CM öppnar kontor i Köpenhamn för att erbjuda närmare och mer respons stöd till nordiska och europeiska universitet
för institutioner att fatta datadrivna beslut och uppnå sina registreringsmål. Med kontor i Kanada, Storbritannien och nu Danmark fortsätter Azorus att öka sin närvaro i hela Europa och stötta högre utbildningsinstitutioner med teknik som är utformad för deras unika behov.Logotyp -
More news about: AZORUS CRM
Dec 08, 2025, 18:30 ET Club Med Expands Brand Presence in Canada with the Announcement of Club Med Tremblant
of Club Med Québec Charlevoix.MONT-TREMBLANT, QC, Dec. 8, 2025 /PRNewswire/ -- Club Med, the world leader in premium all-inclusive mountain and beach resorts, today announced the development of Club Med Tremblant,
More news about: Club Med
Dec 08, 2025, 16:13 ET Hikma launches TYZAVAN™ (vancomycin injection, USP) in the US
Carroll D, Popa A, Hejal R, et al. 1601: Evaluation of timing of first dose antibiotic administration in patients with sepsis or septic shock. Crit Care Med. 2019;47(1):776
More news about: Hikma Pharmaceuticals USA Inc.
Dec 08, 2025, 12:00 ET Castlight Health Partners With Noom to Expand Access to Personalized Programs for Weight and Chronic Conditions
seamlessly discover, access, and enroll in Noom programs – including Noom Weight, Noom Med, Noom Diabetes, and Noom Diabetes Prevention – directly through the Castlight app. Members also gain access to GLP-1s through Noom Med, helping those prescribed these medications integrate them effectively with lifestyle
More news about: Castlight Health